Information  X 
Enter a valid email address

Summit Corporation PLC (SUMM)

  Print      Mail a friend

Thursday 18 August, 2011

Summit Corporation PLC


Summit Corporation plc
("Summit" or "the Company")


Oxford, UK, 18 August 2011, Summit (AIM: SUMM), a UK drug discovery Company,
announces that it will be releasing its interim financial results for the six
months ended 31 July 2011 on 23 August 2011.

                                    - END -

For more information, please contact:


 Barry Price, PhD,

 Richard Pye, PhD                             Tel: +44 (0)1235 443 939

 Singer Capital Markets (Nominated Adviser)

 Shaun Dobson / Claes SpÄng                   Tel: +44 (0)20 3205 7500

 Peckwater PR

 Tarquin Edwards                              Tel: +44 (0)7879 458 364

Notes to Editors

About Summit
Summit is an Oxford, UK based drug discovery company with an innovative
technology platform called
Seglins for the discovery of new medicines, a portfolio of drug programme assets
and a commercial
strategy of signing multiple early-stage deals.

Seglin(TM) technology is using new chemistry to access biological drug targets
that cannot be exploited by
conventional drug discovery approaches. Summit's internal research is currently
focussed in the high-value therapy areas and the Company will further exploit
the technology's wider potential through strategic alliances. Summit's programme
portfolio consists of a number of drug programmes targeting high-value areas of
unmet medical need including Duchenne Muscular Dystrophy and C. difficile

Summit's commercial strategy focuses on signing multiple early-stage drug
programme and technology
platform deals that generate upfront cash, remove development costs from the
Company, and retain
valuable upside potential.

Summit is listed on the AIM market of the London Stock Exchange and trades under
the ticker symbol
SUMM. Further information is available

This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
Source: Summit Corporation PLC via Thomson Reuters ONE